Skip to content

Clinical trials

Stroke trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Country / region: Saudi Arabia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20132
20162
20173
20181
20201
20214
20221
20235
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting6
Not yet recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King Saud University8
Umm Al-Qura University4
University of Jazan3
Boston Scientific Corporation2
Majmaah University2
AstraZeneca1
Bayer1
Boehringer Ingelheim1
Cairo University1
Karthick Balasubramanian1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke27
Atrial Fibrillation4
Hemiplegia4
Ischemic Stroke4
Hemorrhagic Stroke3
Paresis3
Brain Diseases1
Central Nervous System Diseases1
Embolism1
Hemorrhage1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.